Suppr超能文献

白细胞介素-2 相关调节性 CD4+T 细胞缺陷在系统性硬化症小鼠模型中肺纤维化和血管重构发展中的驱动作用。

Driving Role of Interleukin-2-Related Regulatory CD4+ T Cell Deficiency in the Development of Lung Fibrosis and Vascular Remodeling in a Mouse Model of Systemic Sclerosis.

机构信息

Université de Paris, Inserm U1016, CNRS UMR 8104, and Cochin Hospital, Paris, France.

Université de Paris, Inserm U1016, CNRS UMR 8104, Paris, France.

出版信息

Arthritis Rheumatol. 2022 Aug;74(8):1387-1398. doi: 10.1002/art.42111. Epub 2022 Jun 28.

Abstract

OBJECTIVE

Systemic sclerosis (SSc) is a debilitating autoimmune disease characterized by severe lung outcomes resulting in reduced life expectancy. Fra-2-transgenic mice offer the opportunity to decipher the relationships between the immune system and lung fibrosis. This study was undertaken to investigate whether the Fra-2-transgenic mouse lung phenotype may result from an imbalance between the effector and regulatory arms in the CD4+ T cell compartment.

METHODS

We first used multicolor flow cytometry to extensively characterize homeostasis and the phenotype of peripheral CD4+ T cells from Fra-2-transgenic mice and control mice. We then tested different treatments for their effectiveness in restoring CD4+ Treg cell homeostasis, including adoptive transfer of Treg cells and treatment with low-dose interleukin-2 (IL-2).

RESULTS

Fra-2-transgenic mice demonstrated a marked decrease in the proportion and absolute number of peripheral Treg cells that preceded accumulation of activated, T helper cell type 2-polarized, CD4+ T cells. This defect in Treg cell homeostasis was derived from a combination of mechanisms including impaired generation of these cells in both the thymus and the periphery. The impaired ability of peripheral conventional CD4+ T cells to produce IL-2 may greatly contribute to Treg cell deficiency in Fra-2-transgenic mice. Notably, adoptive transfer of Treg cells, low-dose IL-2 therapy, or combination therapy changed the phenotype of Fra-2-transgenic mice, resulting in a significant reduction in pulmonary parenchymal fibrosis and vascular remodeling in the lungs.

CONCLUSION

Immunotherapies for restoring Treg cell homeostasis could be relevant in SSc. An intervention based on low-dose IL-2 injections, as is already proposed in other autoimmune diseases, could be the most suitable treatment modality for restoring Treg cell homeostasis for future research.

摘要

目的

系统性硬化症(SSc)是一种使人衰弱的自身免疫性疾病,其肺部严重病变导致预期寿命缩短。Fra-2 转基因小鼠为阐明免疫系统与肺纤维化之间的关系提供了机会。本研究旨在探讨 Fra-2 转基因小鼠的肺部表型是否源于 CD4+T 细胞区室中效应器和调节臂之间的失衡。

方法

我们首先使用多色流式细胞术来广泛描述 Fra-2 转基因小鼠和对照小鼠的外周 CD4+T 细胞的稳态和表型。然后,我们测试了不同的治疗方法对恢复 CD4+Treg 细胞稳态的有效性,包括 Treg 细胞的过继转移和低剂量白细胞介素-2(IL-2)的治疗。

结果

Fra-2 转基因小鼠表现出外周 Treg 细胞比例和绝对数量的显著减少,随后出现活化的、辅助性 T 细胞 2 极化的 CD4+T 细胞的积累。这种 Treg 细胞稳态缺陷源于多种机制,包括在胸腺和外周中这些细胞的生成受损。外周常规 CD4+T 细胞产生 IL-2 的能力受损可能极大地促成了 Fra-2 转基因小鼠中的 Treg 细胞缺陷。值得注意的是,Treg 细胞过继转移、低剂量 IL-2 治疗或联合治疗改变了 Fra-2 转基因小鼠的表型,导致肺部实质纤维化和血管重塑显著减少。

结论

恢复 Treg 细胞稳态的免疫疗法可能与 SSc 相关。基于低剂量 IL-2 注射的干预措施,如已经在其他自身免疫性疾病中提出的那样,可能是恢复 Treg 细胞稳态的最适合治疗方式,为未来的研究提供了思路。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验